ERS Genomics Jun 28 New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge by ERS Genomics | June 28, 2022 1126 Dublin, Ireland | ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge access to ... Read more > Press Release Corporate FluidFM Applications Jun 28, 2022
Stony Brook University (SUNY) Jun 22 Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processes by Stony Brook University (SUNY) | June 22, 2022 1086 Stony Brook, NY | Gábor Balázsi , PhD, and his research team in the Laufer Center and the Department of Biomedical Engineering at Stony Brook University are embarking upon a new way to research cells,... Read more > Press Release Corporate FluidFM Applications Jun 22, 2022
Claudia Frey Mar 30 Cytosurge launches cell line engineering services based on proprietary FluidFM® technology by Claudia Frey | March 30, 2022 1446 Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press Release Corporate FluidFM Applications Mar 30, 2022
Claudia Frey Jan 18 R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse by Claudia Frey | January 18, 2022 1415 Zurich | Cytosurge , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) at the Swiss Fe... Read more > Press Release Corporate FluidFM Applications Jan 18, 2022
Claudia Frey Aug 04 Partnership between Central Scientific Commerce and Cytosurge by Claudia Frey | August 4, 2021 1822 Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press Release Corporate Aug 4, 2021
Claudia Frey Mar 24 Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks by Claudia Frey | March 24, 2021 1701 Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more > Press Release Corporate FluidFM Applications Mar 24, 2021
Claudia Frey Jul 23 Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas by Claudia Frey | July 23, 2020 1848 Waltham, Mass. & Zurich | Olympus , a leading manufacturer of high-end research microscopes, and Cytosurge , a precision manufacturer of cell manipulation technologies, have entered a co-marketing agr... Read more > Press Release Corporate Jul 23, 2020
Claudia Frey May 04 Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editing by Claudia Frey | May 4, 2020 2617 Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG , a company manufacturing unique high-precision nanotech... Read more > Press Release Corporate FluidFM Applications May 4, 2020
Claudia Frey Jul 09 Partnership between Olympus Europe & Cytosurge by Claudia Frey | July 9, 2019 2500 Zurich & Hamburg | Olympus Europe and Cytosurge have partnered in order to accelerate common innovation of next-generation tools for single cell experiments and to expand the distribution of the versa... Read more > Press Release Corporate Jul 9, 2019
Claudia Frey Jun 29 Premium Partnership between Bruker & Cytosurge by Claudia Frey | June 29, 2018 1477 Zurich | Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, a... Read more > Press Release Corporate Jun 29, 2018
Claudia Frey Dec 07 Partnership between JPK Instruments & Cytosurge by Claudia Frey | December 7, 2017 1383 Zurich | Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading m... Read more > Press Release Corporate Dec 7, 2017
Claudia Frey Oct 18 Premium Partnership between Nanosurf & Cytosurge by Claudia Frey | October 18, 2017 1389 Zurich | Cytosurge and Nanosurf have a long-standing and successful history together in establishing FluidFM ® system solutions. This has resulted in over 40 publications generated by 30+ systems in t... Read more > Press Release Corporate Oct 18, 2017
